Galderma Group N (GALD) — Strategic Asset Allocation Index
Galderma Group N (GALD) has a Strategic Asset Allocation Index of 8.7% as of June 2025. Strategic assets (PP&E of CHF672.00 Million plus long-term investments of CHF-) total CHF672.00 Million, measured against net assets of CHF7.73 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Galderma Group N Strategic Asset Allocation Index (2022–2024)
This chart shows how Galderma Group N's Strategic Asset Allocation Index has evolved across 3 annual periods from 2022 to 2024. As of June 2025, the index stands at 8.7%, representing strategic assets of CHF672.00 Million against net assets of CHF7.73 Billion CHF. Explore Galderma Group N (GALD) cash flow conversion to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Galderma Group N (2022–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for Galderma Group N from 2022 to 2024, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Galderma Group N market cap and net worth.
| Year | SAAI | Strategic Assets (CHF) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 7.4% | CHF577.00 Million | CHF577.00 Million | CHF- | CHF7.79 Billion | ▼ -4.3 pp |
| 2023 | 11.7% | CHF529.20 Million | CHF529.20 Million | CHF- | CHF4.52 Billion | ▲ +2.0 pp |
| 2022 | 9.7% | CHF400.80 Million | CHF400.80 Million | CHF- | CHF4.13 Billion | — |